The percentage of differentiated Th cells by APCs in the experimental models of liver disease was significantly reduced with the norfloxacin treatment in the CCl4 model (Figure 8C), whereas it didn’t induce significant changes in the BDL model, except for IFNg and IL-17 by LSECs (Figure 8D). This evidence concerns the gene IL17A and liver disorder.